The primary results of the TRANSFORM II
The primary results of the TRANSFORM II trial were presented as a Late-Breaking Clinical Trial at TCT 2026 on 1 November, and the study has been accepted in The Lancet. TRANSFORM II is an investigator-driven, randomised trial comparing the MagicTouch sirolimus-coated balloon (SCB) with an everolimus-eluting stent (EES) in de novo native coronary vessels. It…
